The introduction of AI across an expansive ecosystem of endpoints poses unique challenges for IT buyers and directors.
Cardiovascular disease remains the leading global killer. Still, too many late-stage cardiology trials stumble, not for lack of biology, but because episodic, clinic-bound measures miss what matters ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback